This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

RF Industries Reports Preliminary Second Quarter Results

RF Industries, Ltd. (NASDAQ:RFIL) today announced preliminary results for the second quarter ended April 30, 2012. Net income increased 48% to a second quarter record $602,000, or $0.08 per diluted share, compared to net income of $407,000, or $0.06 per diluted share, in the same period last year. Net sales increased 52% to a record $6,672,000 compared to $4,392,000 in the same period last year, reflecting additional sales of $1,836,000 from Cables Unlimited, Inc., which was acquired in June, 2011.

The Company also announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per common share, payable July 16, 2012 to shareholders of record on June 30, 2012.

Second Quarter Review

"Preliminary second quarter results reflect additional sales from Cables Unlimited, Inc., acquired in the third quarter last year, record sales at Bioconnect, RFI's Medical Cabling and Interconnector segment, and a significant improvement in RF Wireless sales and profitability. We anticipate that growing sales at RF Wireless, better pricing at RF Connector & Cable Assembly and the introduction of new products will lead to improved results for the remainder of fiscal 2012," said Howard Hill, RFI's CEO.

Sales at the RF Connector and Cable Assembly segment were off 1% to $3,416,000 compared to $3,463,000 in the same period last year. Connector and Cable division sales increased 4% compared to the second quarter last year, while sales at Aviel and Oddcables declined by over 30% from the same period last year. Segment profitability was primarily affected by lower margins at the Connector and Cable Assembly division. Pre-tax income for this segment was $382,000 compared to $609,000 in the second quarter last year.

Bioconnect sales increased 11% to a record $768,000 compared to $691,000 in the second quarter last year. Improvements in manufacturing and productivity for this business resulted in a reduced cost of goods sold, raising gross margin to 46%, compared to 39% of sales in the same period last year. Pre-tax income increased 49% to $257,000 compared to $172,000 in the second quarter last year.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs